{"result": "(\"entity\"<|>HOSPITAL ROYO VILLANOVA<|>ORGANIZATION<|>Hospital Royo Villanova is a medical facility located in Zaragoza, specializing in endocrinology and nutrition.)\n##\n(\"entity\"<|>CONCEPCIÓN VIDAL PERACHO<|>PERSON<|>Dra. Concepción Vidal Peracho is a specialist in endocrinology and nutrition at Hospital Royo Villanova.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 1<|>EVENT<|>Diabetes Mellitus Type 1 is a chronic condition characterized by high blood sugar levels due to the body's inability to produce insulin.)\n##\n(\"entity\"<|>PANCREATIC CANCER<|>EVENT<|>Pancreatic cancer is a highly aggressive form of cancer that affects the pancreas, often diagnosed late due to lack of symptoms.)\n##\n(\"entity\"<|>BICI<|>ORGANIZATION<|>BICI stands for Infusor Subcutáneo Continuo de Insulina, a device used for continuous insulin delivery in diabetes management.)\n##\n(\"entity\"<|>ADENOCARCINOMA PANCREATICO DUCTAL<|>EVENT<|>Adenocarcinoma pancreático ductal is the most common type of pancreatic cancer, known for its aggressive nature and low survival rates.)\n##\n(\"relationship\"<|>CONCEPCIÓN VIDAL PERACHO<|>HOSPITAL ROYO VILLANOVA<|>Dra. Concepción Vidal Peracho works as a specialist at Hospital Royo Villanova<|>9)\n##\n(\"relationship\"<|>BICI<|>DIABETES MELLITUS TYPE 1<|>BICI is used to manage Diabetes Mellitus Type 1 by providing continuous insulin delivery<|>8)\n##\n(\"relationship\"<|>PANCREATIC CANCER<|>DIABETES MELLITUS TYPE 1<|>The patient with Diabetes Mellitus Type 1 developed pancreatic cancer, indicating a potential link between the two conditions<|>5)\n##\n(\"relationship\"<|>ADENOCARCINOMA PANCREATICO DUCTAL<|>PANCREATIC CANCER<|>Adenocarcinoma pancreático ductal is a specific type of pancreatic cancer<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: O’Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than\n     manometric diagnosis. Gastroenterology. 1995;108(4):1024-9.\n\n\n\n     14.  Sanz-Paris A, Álvarez-Hernández J, Ballesteros-Pomar MD, Botella-Romero F, León-Sanz M,\n     Martín-Palmero Á, et al. Evidence-based recommendations and expert consensus on enteral nutrition\n     in the adult patient with diabetes mellitus or hyperglycemia. Nutrition. 2017;41:58-67.\n\n\n\n172\n---\n   Caso Clínico\nNutrición y cáncer de páncreas en un\npaciente con DM tipo 1 portador de una\nBICI       (Infusor subcutáneo continuo de insulina)\nDra. Concepción Vidal Peracho\nMédico Especialista en Endocrinología y Nutrición.\nHospital Royo Villanova de Zaragoza.\n\n\n\nResumen\n         Se trata de un paciente con DM1 de mas de treinta años de evolución que ha-\nbía presentado siempre gran variabilidad glucémica, diabetes lábil, con hipoglucemias\nprofundas, al que se le coloca un infusor subcutáneo de insulina en 2015, que consigue\nmejorar su calidad de vida con disminución de las hipoglucemias. La aparición de un\ncáncer de páncreas silente, 2018, localizado en cola de páncreas con metástasis y la\nrápida progresión de la disminución ponderal, en un paciente con SNO específicos, sin\ningresos hospitalarios prolongados salvo anemia y síndrome febril e hiperglucemia en\nrelación con la quimioterapia, no evito la caquexia progresiva y el fallecimiento tempra-\nno. El paciente se mantuvo controlado de su DM. No presentó insuficiencia pancreática\nexocrina. Se utilizó acetato de medroxiprogesterona y dexametasona en el tratamiento\nsintomático del síndrome paraneoplásico.\n\n\n\nPalabras clave\n         Tumor    pancreático     exocrino,   Diabetes    mellitus    insulinodependiente,  infusor\nsubcutáneo continuo de insulina (BICI).\n\n\n\nIntroducción\n         El ADENOCARCINOMA PANCREATICO DUCTAL (PDAC) es la forma más común de\ncáncer de páncreas con un aumento de la prevalencia en los últimos 10 años. Es un\ntumor muy agresivo con una supervivencia media a los 5 años del 7,2% y, a los 10 años,\ninferior al 4%. En 80% de los casos el diagnóstico es tardío por ausencia de síntomas.\nUn 60-70% se localizan en cabeza de páncreas, 20-25% cuerpo y 10-20% en cola. Los\nprimeros se diagnostican antes por la obstrucción biliar que ocasionan y, los de otras\nlocalizaciones, en estadios más avanzados, por falta de sintomatología1  .\n\n\n\n         La clínica habitual es de fatigabilidad, anorexia, disminución de peso, dolor\nabdominal y coluria1  . Solo 7-25% de los pacientes con cáncer resecable sobreviven a\n\n\n\n                                                                                                     173\n---\n     los 5 años y, en la enfermedad metastática, entre 6-11 meses tras el diagnostico según\n     datos del Cancer Research. Si el cáncer está localizado la supervivencia a los 5 años es\n     del 29%, del 11% si afectación linfática regional y 2,65 si hay metástasis2 .\n              El diagnóstico se realiza mediante eco abdominal, Tac bifásico en el que se\n     detecta en la fase arterial como una lesión hipodensa, con bordes poco definidos. La\n     RNM abdominal, por su alto coste, se reserva para casos difíciles, neoplasias quísticas\n     y evaluación de vías biliares. La gastroscopia, se realiza si hay sospecha que el tumor\n     infiltra duodeno. La punción de la masa abdominal con ecografía tiene 90% de sensi-\n     bilidad y 98% de especificidad y, de los diferentes marcadores tumorales, Ca 19.9 tiene\n     una sensibilidad y especificidad de hasta 92%1 .\n              Dada la rápida progresión clínica se recomienda que el inicio del tratamiento\n     sea inferior a dos semanas para la cirugía, una semana para la quimioterapia y cuatro\n     semanas para la radioterapia. El tratamiento previo a la cirugía, con quimioterapia y/o\n     radioterapia, forma parte de la evaluación de la comisión de tumores de cada hospital1 .\n     El tratamiento quirúrgico es de elección, aunque de forma previa el estado nutricional\n     debe ser el adecuado, mediante SNO o NPT 1-2 semanas antes de cirugía, en pacien-\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}